Solabia Group is a France‑based life sciences and specialty ingredients manufacturer serving the cosmetics and personal care, nutrition, pharmaceutical, and diagnostic markets. The company develops and produces active ingredients, excipients, and microbiology media used by industrial and brand customers worldwide.
Its portfolio includes plant- and marine‑derived extracts, microalgae ingredients, polysaccharides and other biopolymers, along with fermentation- and enzymatic‑synthesis products and diagnostic reagents. Solabia operates R&D and manufacturing sites in Europe and internationally, combining biotechnology, extraction, and green chemistry capabilities to supply regulated and performance ingredients for formulation and analytical use.
None yet. When a new project in the record names Solabia Group as owner, partner or investor, it shows here.
The sale aligns with SEQENS' focus on core activities, while Solabia's expertise supports the Limoges site's growth in personal care and life sciences.
